James Gregoire, Charles Britt, Amrita Srivastava, James Koenig, Zoe Strickland, Henry Schober
The “Join Session” button will become active on the day of the conference.
Amid the COVID-19 pandemic, companies worldwide are facing unprecedented health and safety risks, operational and logistical challenges, and dilemmas regarding the balance between customer/employee safety and data privacy. What obligations do companies have with respect to data collection, use and sharing to detect and/or prevent the spread of the virus? Questions abound regarding the provision of notice, disclosures for confirmed or suspected diagnoses, the preferred approach for contact tracing, and more. In this session, our panel will describe some of the toughest challenges being faced by companies today and review the key guidance issued by 50+ U.S. and global data protection authorities and governmental agencies on health data collection, COVID-19 diagnosis disclosure and work-at-home practices. In a time of diverse and divergent voices and chaos, we will highlight the 10 critical actions every company should be taking to maintain order in their privacy and security house.
James Gregoire, Managing Director, Privacy & Cybersecurity Practice, Fenwick & West
Amrita Srivastava, Associate General Counsel-US, Coupang
Charles Britt, Senior Privacy Counsel, NCR Corporation
James Koenig, Partner, Fenwick & West
Zoe Strickland, VP Global Privacy and US Commercial Compliance, Cigna
Henry Schober, Global Privacy Director and Data Protection Officer, Align Technology
Readings:
